Fibroblasts

University of Birmingham-Led Study Reveals Autoimmune Disease Treatment May Benefit from the Re-Purposing of Existing Drugs

Jun 18, 2019 | Autoimmune Disease, Fibroblasts, Immune System, Inflammation

A collaborative research effort led by the University of Birmingham’s Institute of Inflammation of Ageing and Institute of Cardiovascular Sciences along with the University of Oxford, University of Cambridge, University of York, University of Rennes (France) and the...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

University of Birmingham-Led Study Reveals Autoimmune Disease Treatment May Benefit from the Re-Purposing of Existing Drugs

Pin It on Pinterest